TET3 and hepatocellular carcinoma: In addition, ChIP‐qPCR experiments were performed in MDA‐MB‐231 and HCC‐1806 cell lines to demonstrate that TET3 could bind to the IGF2BP3 promoter region (Figure S1k,l).